# Repaglinide Tablets 0.5mg "Sawai" (レパグリニド錠０．５ｍｇ「サワイ」)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3969013F2034). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3969013F2034
- **Product name (Japanese):** レパグリニド錠０．５ｍｇ「サワイ」
- **Product name (English):** Repaglinide Tablets 0.5mg "Sawai"
- **Active ingredient:** レパグリニド
- **Active ingredient (INN):** Repaglinide
- **Strength / unit:** ０．５ｍｇ１錠
- **Route:** Oral (内用薬)
- **Therapeutic category:** 39 Other metabolic agents (その他の代謝性医薬品) › 396 Antidiabetics (糖尿病用剤)
- **Manufacturer:** Sawai Pharmaceutical (沢井製薬)
- **Brand / generic:** Generic (後発医薬品)
- **NHI price (reference only):** JPY 10.8 per ０．５ｍｇ１錠
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3969013F2034
- **JSON:** https://www.nifujipharma.com/api/drugs/3969013F2034

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Repaglinide%20Tablets%200.5mg%20%22Sawai%22%20(%E3%83%AC%E3%83%91%E3%82%B0%E3%83%AA%E3%83%8B%E3%83%89%E9%8C%A0%EF%BC%90%EF%BC%8E%EF%BC%95%EF%BD%8D%EF%BD%87%E3%80%8C%E3%82%B5%E3%83%AF%E3%82%A4%E3%80%8D)%20%2F%20YJ%203969013F2034#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Repaglinide

- [Repaglinide Tablets 0.25mg "Sawai" (レパグリニド錠０．２５ｍｇ「サワイ」)](https://www.nifujipharma.com/drugs/3969013F1038) — ０．２５ｍｇ１錠, Sawai Pharmaceutical, generic